“Vaccine for the world” approved for emergency use in the UK
LONDON (AP) — Britain has authorized use of a second COVID-19 vaccine, becoming the first country to greenlight an easy-to-handle shot that its developers hope will become the “vaccine for the world.”
The United Kingdom government says the Medicines and Healthcare Products Regulatory Agency has made an emergency authorization for the vaccine developed by Oxford University and UK-based drugmaker AstraZeneca.
The company is still awaiting emergency use authorization from the U.S. Food and Drug Administration to begin distribution in the states.
Chief executive for AstraZeneca, Pascal Soriot, said “today is an important day for millions of people in the U.K. who will get access to this new vaccine. It has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit.”